Joining Slice of Life Sciences Real Estate today is Roger Frechette who is a life sciences consultant/advisor, helping early-stage life science companies to succeed and to grow. His work with clients leverages an extensive global network and multi-disciplinary insights derived from over 20 years of experience in the business of life sciences, calibrated with an extensive science background.

In this episode you'll learn about:

• Frechette’s background
• His experience with co-founding a company, and the company’s story
• The services New England PharmAssociates specializes in
• His role as Vice Chair of Life Sciences for the Boston Entrepreneurs’ Network and the events they put on
• Common themes he’s observed over the years from the innovators and companies he has worked with
• The primary piece of advice he would give to someone about to start a company in the biotech industry

For more information on New England PharmAssociates please follow this link:
- LinkedIn

This podcast is produced by Slice of Media, INC.

Hi everyone and welcome to episode #12 of Slice of Life Sciences.

We have a great conversation lined up today as we are joined by Chris Bahl, Chief Scientific Officer and Co-Founder of AI Proteins. I have gotten to know Chris this past year, which makes me especially excited to hear about his journey and how it led to this newly founded biotech company focused on the design and engineering of synthetic miniprotein therapeutics.

In this episode you'll learn about:

• Bahl's background & what made him want to study protein
• How AI Proteins came about
• The challenges AI Proteins is solving
• The culture of AI Proteins
• Milestones they are looking to hit
• What Bahl is most excited about for the future of AI Proteins
• Advice he would give to aspiring entrepreneurs

For more information on AI Proteins please follow these links:
- Website - LinkedIn

This podcast is produced by Slice of Media, INC.

Thanks everybody for joining us on episode #11 of Slice of Life Sciences.

I’m very much looking forward to today’s episode as I am joined by Jake Lombardo, Co-Founder and CEO at Anodyne Nanotech, which is a venture-backed, preclinical-stage biotech company developing differentiated, transdermal forms of high-value drugs.

In this episode you'll learn about:

• Lombardo's background
  • Where he grew up, and how he gained interest in biotech
  • His mentors that inspired him early on
  • His time at Union College, and his research projects there
  • His time at Tufts University’s Gordon Institute to receive a Master of Science in Innovation and Management
• The founding of Anodyne Nanotech
  • the genesis of the company
  • The problem the Anodyne team is solving and what applications on the world their science/technology can have
• The Hero Patch
  • Pharmaceutical partners that Anodyne is working with
• The seed round received last April
  • What this means for the growth of Anodyne, and what the investment been put towards
• The challenges Lombardo has faced with Anodyne Nanotech, and what continues to excite him
• How he's juggled hiring, fundraising, and managing a team?
• and about being an entrepreneur:
  • Was there a specific moment Lombardo knew he wanted to be an entrepreneur, or did it happen organically? And
  • any advice he’d give to another ‘Jake Lombardo’ getting his master’s about to start a company?

Jake, thanks so much for taking the time to chat with us...can’t wait to continue hearing about your

teams’ successes and growth!

This podcast is produced by Slice of Media, INC.